Nur77 modulator 3

Name: Nur77 modulator 3
Brand: MedChemExpress
SKU: HY-162147
Rating: 4.5 (0 reviews)

Cat. No.: HY-162147 Purity: 99.01%: Data Sheet
COA

SDS
Handling Instructions
FAQs
Technical Support

Nur77 modulator 3 is a Nur77 modulator. Nur77 modulator 3 induces Nur77 expression, inhibits hepatic stellate cells (HSCs) activation, and reduces extracellular matrix (ECM) deposition. Nur77 modulator 3 enhances Nur77-denpendent autophagic flux and significantly inhibits the mTORC1 signaling pathway. Nur77 modulator 3 ameliorates HSCs activation, inflammation and hepatic fibrosis in vivo.

For research use only. We do not sell to patients.

Nur77 modulator 3 Chemical Structure

CAS No. : 2097787-75-0

Size	Stock	Quantity
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO ready for reconstitution	In-stock	Estimated Time of Arrival: December 31
Solution
10 mM * 1 mL in DMSO	In-stock	Estimated Time of Arrival: December 31
Solid
5 mg	In-stock	Estimated Time of Arrival: December 31
10 mg	In-stock	Estimated Time of Arrival: December 31
25 mg	In-stock	Estimated Time of Arrival: December 31
50 mg	In-stock	Estimated Time of Arrival: December 31
100 mg	In-stock	Estimated Time of Arrival: December 31
200 mg	Get quote
500 mg	Get quote

or Bulk Inquiry

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 Customer Validation

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

View All Nuclear Hormone Receptor 4A/NR4A Isoform Specific Products:

View All Isoforms

Nur77/NR4A1 Nurr1/NR4A2

View All mTOR Isoform Specific Products:

View All Isoforms

mTOR mTORC1 mTORC2

Biological Activity
Purity & Documentation
References
Customer Review

Description

IC₅₀ & Target^[1]

Nur77/NR4A1

mTORC1

Cellular Effect

Cell Line	Type	Value	Description	References
786-0	GI₅₀	3.99 μM Compound: 2c	Growth inhibition of human 786-0 cells after 48 hrs by sulforhodamine B dye-based spectrophotometric assay Growth inhibition of human 786-0 cells after 48 hrs by sulforhodamine B dye-based spectrophotometric assay	[PMID: 28505535]
HT-29	GI₅₀	1.45 μM Compound: 2c	Growth inhibition of human HT-29 cells after 48 hrs by sulforhodamine B dye-based spectrophotometric assay Growth inhibition of human HT-29 cells after 48 hrs by sulforhodamine B dye-based spectrophotometric assay	[PMID: 28505535]
HaCaT	GI₅₀	0.99 μM Compound: 2c	Growth inhibition of human HaCaT cells after 48 hrs by sulforhodamine B dye-based spectrophotometric assay Growth inhibition of human HaCaT cells after 48 hrs by sulforhodamine B dye-based spectrophotometric assay	[PMID: 28505535]
K562	GI₅₀	0.16 μM Compound: 2c	Growth inhibition of human K562 cells after 48 hrs by sulforhodamine B dye-based spectrophotometric assay Growth inhibition of human K562 cells after 48 hrs by sulforhodamine B dye-based spectrophotometric assay	[PMID: 28505535]
MCF7	GI₅₀	2.52 μM Compound: 2c	Growth inhibition of human MCF7 cells after 48 hrs by sulforhodamine B dye-based spectrophotometric assay Growth inhibition of human MCF7 cells after 48 hrs by sulforhodamine B dye-based spectrophotometric assay	[PMID: 28505535]
NCI-H460	GI₅₀	11.72 μM Compound: 2c	Growth inhibition of human NCI-H460 cells after 48 hrs by sulforhodamine B dye-based spectrophotometric assay Growth inhibition of human NCI-H460 cells after 48 hrs by sulforhodamine B dye-based spectrophotometric assay	[PMID: 28505535]
NCI/ADR-RES	GI₅₀	1.46 μM Compound: 2c	Growth inhibition of human NCI-ADR-RES cells after 48 hrs by sulforhodamine B dye-based spectrophotometric assay Growth inhibition of human NCI-ADR-RES cells after 48 hrs by sulforhodamine B dye-based spectrophotometric assay	[PMID: 28505535]
OVCAR-3	GI₅₀	3.88 μM Compound: 2c	Growth inhibition of human OVCAR3 cells after 48 hrs by sulforhodamine B dye-based spectrophotometric assay Growth inhibition of human OVCAR3 cells after 48 hrs by sulforhodamine B dye-based spectrophotometric assay	[PMID: 28505535]
U-251	GI₅₀	8.11 μM Compound: 2c	Growth inhibition of human U251 cells after 48 hrs by sulforhodamine B dye-based spectrophotometric assay Growth inhibition of human U251 cells after 48 hrs by sulforhodamine B dye-based spectrophotometric assay	[PMID: 28505535]

In Vitro

Nur77 modulator 3 (Compound 9e) (5 and 10 μM, 24 h) inhibits TGF-β1-induced HSCs (LX-2, HSC-T6) activation in a Nur77-dependent manner^[1].
Nur77 modulator 3 (5 and 10 μM, 36 h) inhibits TGF-β1-mediated HSCs (LX-2) activation by promoting autophagic flux^[1].
Nur77 modulator 3 (5 and 10 μM, 24 h) enhances autophagic flux by inhibiting TGF-β1-induced mTOR phosphorylation in LX-2 cells^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis^[1]

Cell Line:	HSCs (LX-2 and HSC-T6 cell)
Concentration:	5, 10 μM
Incubation Time:	24 h
Result:	Dose-dependently upregulated Nur77 expression, which was downregulated by TGF-β1. Suppressed TGF-β1-mediated α-SMA protein expression.

Cell Autophagy Assay^[1]

Cell Line:	HSCs (LX-2 cell)
Concentration:	5, 10 μM
Incubation Time:	36 h
Result:	Increased LC3B/LC3A ratio but inhibited TGF-β1-induced p62 expression. Induced colocalization of EGFP and mRFP, suggesting that Nur77 modulator 3 promoted autophagic flux. Induced more autophagic vesicles (AVs) and autolysosome-containing engulfed organelles than control cells (TEM assay). Inhibited TGF-β1 induced HSCs activation and ECM deposition, and these effects were greatly reversed by Chloroquine (HY-17589A).

In Vivo

Nur77 modulator 3 (Compound 9e) (20 mg/kg, once daily for 4 weeks) improved HSC activation, inflammation and liver fibrosis in a Carbon tetrachloride (CCl₄) (HY-Y0298)-induced C57 mouse model^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	CCl₄ (2.0 mL/kg, i.p., three weekly for 8 weeks) induced male C57BL/6 mice (6-8 weeks, 20-22 g)^[1]
Dosage:	20 mg/kg
Administration:	i.p., daily, starting from the 4th week until the eighth week.
Result:	Ameliorated tissue disorders in the liver, lung, spleen, and kidney induced by CCl₄. Inhibited the mRNA expression levels of α-SMA, IL-1β and IL-6 up-regulated by CCl₄. Suppressed CCl₄ induced α-SMA and COL1A1 protein production in mouse liver tissue samples.

Molecular Weight

308.40

Formula

C₁₇H₁₆N₄S

CAS No.

2097787-75-0

Appearance

Solid

Color

White to off-white

SMILES

S=C(N/N=C/C1=CNC2=CC=CC=C12)NC3=CC=C(C)C=C3

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Powder	-20°C	3 years
In solvent	-80°C	6 months
	-20°C	1 month

Solvent & Solubility

In Vitro:

DMSO : 250 mg/mL (810.64 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	3.2425 mL	16.2127 mL	32.4254 mL
5 mM	0.6485 mL	3.2425 mL	6.4851 mL
10 mM	0.3243 mL	1.6213 mL	3.2425 mL

View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Molarity Calculator
Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

Concentration _(start)

Volume _(start)

Concentration _(final)

Volume _(final)

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Calculation results:

Working solution concentration: mg/mL

Purity & Documentation

Purity: 99.01%

Select Batch:

Data Sheet (274 KB) SDS (251 KB)

COA (246 KB) HNMR (249 KB) RP-HPLC (250 KB) LCMS (98 KB)

Handling Instructions (2659 KB)

References

[1]. Lin G, et al. Identification of (E)-1-((1H-indol-3-yl)methylene)-4-substitute-thiosemicarbazones as potential anti-hepatic fibrosis agents. Bioorg Chem. 2023 Dec 16;143:107022. [Content Brief]

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg

DMSO	1 mM	3.2425 mL	16.2127 mL	32.4254 mL	81.0636 mL
	5 mM	0.6485 mL	3.2425 mL	6.4851 mL	16.2127 mL
	10 mM	0.3243 mL	1.6213 mL	3.2425 mL	8.1064 mL
	15 mM	0.2162 mL	1.0808 mL	2.1617 mL	5.4042 mL
	20 mM	0.1621 mL	0.8106 mL	1.6213 mL	4.0532 mL
	25 mM	0.1297 mL	0.6485 mL	1.2970 mL	3.2425 mL
	30 mM	0.1081 mL	0.5404 mL	1.0808 mL	2.7021 mL
	40 mM	0.0811 mL	0.4053 mL	0.8106 mL	2.0266 mL
	50 mM	0.0649 mL	0.3243 mL	0.6485 mL	1.6213 mL
	60 mM	0.0540 mL	0.2702 mL	0.5404 mL	1.3511 mL
	80 mM	0.0405 mL	0.2027 mL	0.4053 mL	1.0133 mL
	100 mM	0.0324 mL	0.1621 mL	0.3243 mL	0.8106 mL